STOCKHOLM – May 16 2022 – Markus Hökerberg, CFO of ContextVision, has on May 13th, 2022 purchased 9,562 shares in ContextVision AB at an average price of NOK 7.80 per share. After the transaction, Mr Hökerberg holds a total of 9,562 shares…
ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Gerald Pötzsch as Chief Executive Officer, effective 1st of August 2022. Gerald has solid academic and professional background, holding doctor’s degrees both in Engineering and Medicine…
On the 4th of May 2022, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. Major items approved by the Annual General Meeting include: The annual financial report regarding 2021 was approved by the AGM. Disposition of financial results…
The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8). “It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical…
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding…
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: finance@contextvision.se For inquiries, please contact…
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK…
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15,…
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15,…
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…